Barclays PLC Acquires 20,125 Shares of Doximity, Inc. (NASDAQ:DOCS)

Barclays PLC grew its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 60.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,401 shares of the company’s stock after buying an additional 20,125 shares during the quarter. Barclays PLC’s holdings in Doximity were worth $2,327,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Farther Finance Advisors LLC raised its holdings in Doximity by 324.2% during the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after acquiring an additional 603 shares in the last quarter. Morse Asset Management Inc bought a new position in Doximity in the third quarter valued at approximately $46,000. GAMMA Investing LLC increased its position in shares of Doximity by 40.1% during the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after purchasing an additional 412 shares during the last quarter. Quarry LP raised its stake in shares of Doximity by 101.2% during the 2nd quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after purchasing an additional 131,253 shares in the last quarter. Finally, Covestor Ltd boosted its holdings in shares of Doximity by 441.9% in the 3rd quarter. Covestor Ltd now owns 1,680 shares of the company’s stock valued at $73,000 after buying an additional 1,370 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Price Performance

NASDAQ DOCS opened at $58.27 on Thursday. The business has a fifty day moving average price of $50.00 and a two-hundred day moving average price of $39.47. The stock has a market capitalization of $10.88 billion, a PE ratio of 66.98, a PEG ratio of 4.16 and a beta of 1.40. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $61.75.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. The Goldman Sachs Group began coverage on shares of Doximity in a research report on Friday, November 15th. They set a “neutral” rating and a $58.00 price target on the stock. Morgan Stanley upgraded Doximity from an “underweight” rating to an “equal weight” rating and boosted their price objective for the stock from $33.00 to $53.00 in a report on Thursday, November 14th. Canaccord Genuity Group lowered Doximity from a “buy” rating to a “hold” rating and increased their target price for the stock from $40.00 to $60.00 in a research note on Wednesday, November 13th. Barclays boosted their price target on Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a research note on Monday, November 11th. Finally, Canaccord Genuity Group reissued a “hold” rating and set a $60.00 target price (up previously from $40.00) on shares of Doximity in a report on Wednesday, November 13th. Thirteen research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Doximity currently has an average rating of “Hold” and a consensus price target of $52.59.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.